Valproic acid induced encephalopathy - 19 new cases in Germany from 1994 to 2003 - A side effect associated to VPA-therapy not only in young children

Seizure

Volumn 15, Issue 6, 2006, Pages 443-448

  Gerstner, Thorsten ^a   Buesing, Deike ^a   Longin, Elke ^a   Bendl, Claudia ^a   Wenzel, Dieter ^b   Scheid, Brigitte ^b   Goetze, Gisela ^b   Macke, Alfons ^b   Lippert, Gerhard ^b   Klostermann, Wolfgang ^b   Mayer, Geert ^b   Augspach Hofmann, Regine ^b   Fitzek, Sabine ^b   Haensch, Carl Albrecht ^b   Reuland, Markus ^b   Koenig, Stephan A ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b VPA induced Side Effects Study Group: Children's Hospital Erlangen   (Germany)

Author keywords

Ammonia; Encephalopathy; Side effects; Valproic acid

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLONAZEPAM; ETHOSUXIMIDE; LAMOTRIGINE; OXCARBAZEPINE; PHENOBARBITAL; SULTIAME; TOPIRAMATE; VALPROIC ACID;

ADOLESCENT; ADULT; AGED; ANEMIA; ARTICLE; BLOOD CLOTTING DISORDER; BONE MARROW SUPPRESSION; BRAIN DISEASE; BRAIN EDEMA; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTROLLED STUDY; DISEASE EXACERBATION; DRUG TOLERABILITY; EEG ABNORMALITY; ENTERITIS; EPILEPSY; FEMALE; GERMANY; HEMORRHAGIC PANCREATITIS; HUMAN; HYPERAMMONEMIA; INFANT; ISCHEMIC HEART DISEASE; LIVER DYSFUNCTION; LIVER TOXICITY; MALE; METABOLIC DISORDER; MUSCLE HYPERTONIA; NEUROTOXICITY; PANCREATITIS; PRIORITY JOURNAL; PUBLISHING; SEIZURE;

ADOLESCENT; AGED; ANTICONVULSANTS; BRAIN DISEASES; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERAMMONEMIA; INFANT; MALE; MIDDLE AGED; NEUROTOXICITY SYNDROMES; QUESTIONNAIRES; VALPROIC ACID;

EID: 33747075378     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2006.05.007     Document Type: Article

References (41)

1. Dodge J.C., Illig A.M., Snyder P.J., and Badura L.L. GABA levels within the medial preoptic area: effects of chronic administration of sodium valproic acid. Psychoneuroendocrinology 25 (2000) 519-534
2. Makarska-Bialek K., Kaminski R.M., and Czuczwar S.J. Influence of the antagonist of the glycine site of NMDA receptors, MRZ 2/576, on the anticonvulsant activity of conventional antiepileptic drugs in mice. Pharmacol Rep 57 (2005) 458-466
3. Pugsley M.K., Yu E.J., Mclean T.H., and Goldin A.L. Blockade of neuronal sodium channels by the antiepileptic drugs phenytoin, carbamazepine and sodium valproate. Proc West Pharmacol Soc 42 (1999) 105-108
4. Koenig, Knolle J., Friedewald, Koelfen W., and Hannak G. The effects of valproic acid, carbamazepine and phenobarbitone on the fatty acid composition of erythrocyte membranes in children. Epilepsia 44 (2003) 708-711
5. Koenig S.A. Fatal liver failure associated with valproate therapy in a patient with Friedreich's disease: review of valproate hepatotoxicity in adults. Epilepsia 40 (1999) 1036-1040
6. Yehya N., Saldarini C.T., Koski M.E., and Davanzo P. Valproate induced hyperammonemic encephalopathy. J Am Acad Adolesc Psychiatry 43 (2004) 926-927
7. Teich M., Longin E., Dempfle C.E., and Koenig S.A. Factor XIII deficiency associated with valproat treatment. Epilepsia 45 (2004) 187-189
8. Batalden P.B., Van Dyne B.J., and Cloyd J. Pancreatitis associated with valproic acid therapy. Pediatrics 64 (1979) 520-522
9. Acharya S., and Bussel J.B. Hematologic toxicity of sodium valproate. J Pediatr Hematol Oncol 22 (2000) 62-65
10. Lheureux P.E., Penaloza A., Zahir S., and Gris M. Science review: carnitine in the treatment of valproic acid-induced toxicity-what is the evidence?. Crit Care 9 (2005) 431-440 [Epub 2005 Jun 10]
11. Cuturic M., and Abramson R.K. Acute hyperammonemic coma with chronic valproic acid therapy. Ann Pharmacother 39 (2005) 2119-2122 [Epub 2005 Nov 15]
12. Rath A., Naryanan T.J., Chowdhary G.V., and Murthy J.M. Valproate-induced hyperammonemic encephalopathy with normal liver function. Neurol India 53 (2005) 226-228
13. Longin E., Teich M., Koelfen W., and König S.A. Topiramate enhances the risk of valproate associated side effects in three children. Epilepsia 43 (2002) 451-454
14. Latour P., Biraben A., Polard E., Bentue-Ferrer D., Beauplet A., Tribut O., et al. Drug induced encephalopathy in six epileptic patients: topiramate? valproate? or both?. Hum Psychopharmacol 19 (2004) 193-203
15. Kwan P., and Brodie M.J. Neuropsychological effects of epilepsy and antiepileptic drugs. Lancet 357 (2001) 216-222
16. Duarte J., Macias S., Coria F., Fernandez E., and Claveria L.E. Valproate-induced coma: case report and literature review. Ann Pharmacother 27 (1993) 582-583
17. Ricard C., Martin K., Tournier M., Begaud B., and Verdoux H. A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder. Encephale 31 (2005) 98-101
18. Verrotti A., Trotta D., Morgese G., and Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 17 (2002) 367-373
19. Alonso E., Girbes J., Garcia-Espana A., and Rubio V. Changes in urea cycle-related metabolites in the mouse after combined administration of valproic acid and an amino acid load. Arch Biochem Biophys 272 (1989) 267-273
20. Laub M.C. Hyperammonemia in valproate therapy in children and adolescents. Nervenarzt 57 (1986) 314-318
21. Panda S., and Radhakrishnan K. Two cases of valproate-induced hyperammonemic encephalopathy without hepatic failure. J Assoc Phys India 52 (2004) 746-748
22. O'Neill M., Dubrey R.W., and Grocott-Mason R.M. Valproate encephalopathy and hyperammonaemia. Postgrad Med J 78 (2002) 316-317
23. Verrotti A., Trotta D., Morgese G., and Chiarelli F. Valproate-induced hyperammonemic encephalopathy. Metab Brain Dis 17 (2002) 367-373
24. Osuna M.T., Burcet J., Ramio L., Ustrell X., Silva Y., and Molins A. Hyperammonemic encephalopathy associated with valproate acid. Neurologia 18 (2003) 347-350
25. Elgudin L., Hall Y., and Schubert D. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report. Int J Psychiatry Med 33 (2003) 91-96
26. Lokrantz C.M., Eriksson B., Rosen I., and Asztely F. Hyperammonemic encephalopathy induced by a combination of valproate and pivmecillinam. Acta Neurol Scand 109 (2004) 297-301
27. Payen C., Frantz P., Martin O., Parant F., Moulsma M., Pulce C., et al. Delayed toxicity following acute ingestion of valpromide. Hum Exp Toxicol 23 (2004) 145-148
28. Yehya N., Saldarini C.T., Koski M.E., and Davanzo P. Valproate-induced hyperammonemic encephalopathy. J Am Acad Child Adolesc Psychiatry 43 (2004) 926-927
29. McCall M., and Bourgeois J.A. Valproic acid-induced hyperammonemia: a case report. J Clin Psychopharmacol 24 (2004) 521-526
30. Reif A., Leonhard C., Mossner R., Lesch K.P., and Fallgatter A.J. Encephalopathy and myoclonus triggered by valproic acid. Prog Neuropsychopharmacol Biol Psychiatry 28 (2004) 1061-1063
31. Nakazato Y., Ando S., Yamamoto T., Tamura N., and Shimazu K. Valproate-induced hyperammonemic encephalopathy in a patient with Sjogren's syndrome. Rinsho Shinkeigaku 44 (2004) 682-685
32. Kimmel R.J., Irwin S.A., and Meyer J.M. Valproic acid-associated hyperammonemic encephalopathy: a case report from the psychiatric setting. Int Clin Psychopharmacol 20 (2005) 57-58
33. Hantson P., Grandin C., Duprez T., Nassogne M.C., and Guerit J.M. Comparison of clinical, magnetic resonance and evoked potentials data in a case of valproic-acid-related hyperammonemic coma. Eur Radiol 15 (2005) 59-64
34. Ricard C., Martin K., Tournier M., Begaud B., and Verdoux H. A case of Parkinsonian syndrome, cognitive impairment and hyperammonemia induced by divalproate sodium prescribed for bipolar disorder. Encephale 31 (2005) 98-101
35. Thygesen K.S., and Wolf P. Valproate-caused encephalopathy. Ugeskr Laeger 167 (2005) 3793-3794
36. Cheung E., Wong V., and Fung C.W. Topiramate-valproate-induced hyperammonemic encephalopathy syndrome: case report. J Child Neurol 20 (2005) 157-160
37. Hamer H.M., Knake S., Schomburg U., and Rosenow F. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 54 (2000) 230-232
38. Solomon G.E. Valproate-induced hyperammonemic encephalopathy in the presence of topiramate. Neurology 55 (2000) 606
39. Koenig S.A., Siemes H., Bläker F., Boenigk E., Groß-Selbeck G., Scheffner D., et al. Severe hepatotoxicity during valproate therapy: an update and report of eight new fatalities. Epilepsia 35 (1994) 1005-1015
40. Altunbasak S., Baytok V., Tasouji M., Herguner O., Burgut R., and Kayrin L. Asymptomatic hyperammonemia in children treated with valproic acid. J Child Neurol 12 (1997) 461-463
41. Verrotti A., Greco R., Morgese G., and Chiarelli F. Carnitine deficiency and hyperammonemia in children receiving valproic acid with and without other anticonvulsant drugs. Int J Clin Lab Res 29 (1999) 36-40